Alzheimer’s Disease: Can Memory and Symptoms Be Reversed?

Research published in December 2025 indicates that Alzheimer’s disease may be reversible in animal models, challenging the long-held scientific belief that the condition represents a permanent, one-way neurological decline.

A study led by Kalyani Chaubey of the Pieper Laboratory was published online on December 22, 2025, in Cell Reports Medicine. The research was a collaborative effort involving Case Western Reserve University, University Hospitals, and the Louis Stokes Cleveland VA Medical Center.

The Role of Brain Energy Balance

The research team identified a critical biological driver of Alzheimer’s: the brain’s inability to maintain healthy levels of NAD+, a vital cellular energy molecule. While NAD+ levels naturally decline throughout the body and brain as part of the aging process, this decline is significantly more severe in the brains of individuals with Alzheimer’s.

When the brain lacks proper NAD+ balance, cells become unable to perform essential processes required for their survival and proper functioning. The study found that this collapse in the brain’s energy balance helps drive the progression of the disease.

By studying human Alzheimer’s brain tissue alongside various preclinical mouse models, the researchers tested whether restoring this energy balance could lead to recovery. They discovered that maintaining normal brain NAD+ levels not only prevented Alzheimer’s from developing in animal models but could also reverse the disease in mice that already had advanced Alzheimer’s.

Pathological and Functional Recovery

In the animal models, the treatment resulted in several key improvements:

• The restoration of cognitive function, and memory.
• The repair of brain pathology.
• The normalization of Alzheimer’s biomarkers.

For over a century, medical research has largely focused on preventing the onset of Alzheimer’s or slowing its progression because the disease was considered irreversible once it began. This new evidence suggests that full neurological recovery may be possible, shifting the focus toward potential recovery treatments.

Previous Research on Cognitive Reversal

While the December 2025 findings focused on animal models, earlier small-scale human studies have explored the possibility of reversing memory loss. On October 2, 2014, UCLA Health reported on a small study led by Dr. Dale Bredesen of the UCLA Mary S. Terry Center for Cognitive Aging and Dementia.

That study examined a personalized and comprehensive program designed to reverse memory loss in ten participants. The group included individuals with memory loss associated with Alzheimer’s disease, subjective cognitive impairment, or amnestic mild cognitive impairment.

The results of the 2014 study showed that nine of the ten participants displayed objective or subjective memory improvement within three to six months. Six of those patients, who had previously struggled at their jobs or stopped working, were able to return to work or continue their employment with improved performance.

However, the 2014 study also highlighted limitations in reversal efforts; one participant who had been diagnosed with late-stage Alzheimer’s did not show improvement.

Current Scientific Outlook

The recent findings regarding NAD+ provide a potential biological mechanism for how reversal might be achieved by addressing the energy crisis within brain cells. This offers a different approach from previous decades of research that spent billions of dollars focusing primarily on prevention and slowing progression.

The success seen in the December 2025 animal models suggests that restoring the brain’s energy balance is a viable path for treating advanced stages of the disease, though the research remains in the preclinical phase.